参考文献/References:
[1] FUKUHARA A,MATSUDA M,NISHIZAWA M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307(5708):426-430.
[2] FUJIO Y,MAEDA M,MOHRI T,et al.Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases[J].J Pharmacol Sci,2011,117(4):213-222.
[3] 熊肇军,董吁钢.心肌肥厚的研究进展[J].中国医学前沿杂志,2013,5(4):17-22.
[4] LEE S E,KIM H S.Human resistin in cardiovascular disease[J].J Smooth Muscle Res,2012,48(1):27-35.
[5] MUSE E D,FELDMAN D I,BLAHA M J,et al.The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis[J].Atherosclerosis,2015,239(1):101-108.
[6] KIM M,OH J K,SAKATA S,et al.Role of resistin in cardiac contractility and hypertrophy[J].J Mol Cell Cardiol,2008,45(2):270-280.
[7] DOBRZYN P,PYRKOWSKA A,DUDA M K,et al.Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy[J].Am J Physiol Endocrinol Metab,2013,304(12):1348-1358.
[8] LIU P,CHENG G,QUNHUI Y E,et al.LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9C2 embryonic rat cardiomyocytes[J].Biomed Rep,2016,4(3):387-391.
[9] 雒建卫.Apelin抑制抵抗素诱导的H9C2心肌细胞肥大[D].太原:山西医科大学,2015.
[10] KANG S,CHEMALY E R,HAJJAR R J,et al.Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin(AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1(JNK/IRS1) pathways[J].J Biol Chem,2011,286(21):18465-18473.
[11] SHI J,WEI L.Regulation of JAK/STAT signalling by SOCS in the myocardium[J].Cardiovasc Res,2012,96(3):345-347.
[12] ROHINI A,AGRAWAL N,KOYANI C N,et al.Molecular targets and regulators of cardiac hypertrophy[J].Pharmacol Res,2010,61(4):269-280.
[13] HILFIKER-KLEINER D,SHUKLA P,KLEIN G,et al.Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation,left ventricular rupture,and adverse outcome in subacute myocardial infarction[J].Circulation,2010,122(2):145-155.
相似文献/References:
[1]司澳洋,吕风华,尹宏磊,等.抵抗素通过磷脂酰肌醇3激酶/蛋白激酶B信号通路诱导H9c2心肌细胞肥大机制研究[J].新乡医学院学报,2017,34(7):565.[doi:10.7683/xxyxyxb.2017.07.003]
SI Ao-yang,LYU Feng-hua,YIN Hong-lei,et al.Mechanism of resistin induced H9c2 cardiomyocyte hypertrophy by phosphatidyl inositol 3 kinase/protein kinase signaling pathway[J].Journal of Xinxiang Medical University,2017,34(4):565.[doi:10.7683/xxyxyxb.2017.07.003]
[2]于 乐.膝骨关节炎患者血清脂肪因子水平与颈动脉硬化的相关性[J].新乡医学院学报,2016,33(8):701.[doi:10.7683/xxyxyxb.2016.08.014]
YU Le.Correlation between serum adipokines levels and carotid atherosclerosis in patients with knee osteoarthritis[J].Journal of Xinxiang Medical University,2016,33(4):701.[doi:10.7683/xxyxyxb.2016.08.014]